Zoetis Inc. Files 8-K: Material Agreement, Equity Sales
Ticker: ZTS · Form: 8-K · Filed: Dec 18, 2025 · CIK: 1555280
| Field | Detail |
|---|---|
| Company | Zoetis Inc. (ZTS) |
| Form Type | 8-K |
| Filed Date | Dec 18, 2025 |
| Risk Level | medium |
| Pages | 13 |
| Reading Time | 16 min |
| Key Dollar Amounts | $0.01, $2.0 b, $250 million, $1,969.6 m, $186.6 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, regulation-fd
TL;DR
Zoetis signed a big deal & sold some stock. Details in new 8-K.
AI Summary
On December 15, 2025, Zoetis Inc. entered into a material definitive agreement, potentially involving a direct financial obligation or an off-balance sheet arrangement. The company also reported unregistered sales of equity securities and made a Regulation FD disclosure. This filing was made on December 18, 2025.
Why It Matters
This 8-K filing indicates significant corporate activity for Zoetis Inc., including a new material agreement and equity transactions, which could impact its financial structure and shareholder value.
Risk Assessment
Risk Level: medium — The filing mentions a material definitive agreement and unregistered sales of equity, which can introduce financial obligations and potential dilution, warranting a medium risk assessment.
Key Players & Entities
- Zoetis Inc. (company) — Registrant
- December 15, 2025 (date) — Date of earliest event reported
- December 18, 2025 (date) — Filing date
- 10 Sylvan Way, Parsippany, New Jersey 07054 (location) — Principal executive offices address
FAQ
What type of material definitive agreement did Zoetis Inc. enter into?
The filing indicates Zoetis Inc. entered into a material definitive agreement, but the specific details of the agreement are not provided in this summary.
What was the nature of the unregistered sales of equity securities?
The filing states there were unregistered sales of equity securities, but the specifics of these sales, including the amount and terms, are not detailed here.
What is the significance of the Regulation FD Disclosure?
A Regulation FD Disclosure is made when a company intentionally or unintentionally discloses material non-public information to securities market professionals or investors.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on December 15, 2025.
What is Zoetis Inc.'s principal executive office address?
Zoetis Inc.'s principal executive office is located at 10 Sylvan Way, Parsippany, New Jersey 07054.
Filing Stats: 4,017 words · 16 min read · ~13 pages · Grade level 14.7 · Accepted 2025-12-18 16:17:38
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share ZTS New York Stock Exchan
- $2.0 b — t of the Notes sold in the Offering was $2.0 billion, which includes $250 million in a
- $250 million — fering was $2.0 billion, which includes $250 million in aggregate principal amount of Notes
- $1,969.6 m — eds from the Offering are approximately $1,969.6 million, after deducting the Initial Purc
- $186.6 million — Offering as follows: (i) approximately $186.6 million to fund the cost of entering into the c
- $248.0 million — ons described below, (ii) approximately $248.0 million to purchase approximately 2.1 million s
- $1,535.0 million — e and (iii) the remaining approximately $1,535.0 million for additional repurchases of common st
- $6 billion — cted pursuant to the Company's existing $6 billion share repurchase program and may be mad
- $1,000 — price (as defined in the Indenture) per $1,000 principal amount of Notes for each trad
- $100 million — han all the outstanding Notes, at least $100 million in aggregate principal amount of Notes
- $148.20 — itial conversion price of approximately $148.20 per share of common stock. The initial
- $250,000,000 — tedness for money borrowed in excess of $250,000,000 (or its foreign currency equivalent), i
- $148.2008 — ls each have an initial strike price of $148.2008 per share, subject to certain adjustmen
- $211.7150 — Capped Calls have initial cap prices of $211.7150 per share, subject to certain adjustmen
Filing Documents
- d35588d8k.htm (8-K) — 59KB
- d35588dex41.htm (EX-4.1) — 605KB
- d35588dex101.htm (EX-10.1) — 46KB
- d35588dex102.htm (EX-10.2) — 236KB
- d35588dex991.htm (EX-99.1) — 15KB
- d35588dex992.htm (EX-99.2) — 21KB
- 0001193125-25-324853.txt ( ) — 1299KB
- zts-20251215.xsd (EX-101.SCH) — 3KB
- zts-20251215_lab.xml (EX-101.LAB) — 17KB
- zts-20251215_pre.xml (EX-101.PRE) — 11KB
- d35588d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. The following exhibits are filed as part of this report: Exhibit No. Description 4.1 Indenture, dated as of December 18, 2025, between Zoetis Inc. and Deutsche Bank Trust Company Americas. 4.2 Form of 0.25% Convertible Senior Note due 2029 (included in Exhibit 4.1). 10.1 First Waiver to Revolving Credit Agreement, dated as of December 17, 2025, to the Revolving Credit Agreement dated as of August 27, 2025, among Zoetis Inc., the lenders party thereto, the issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent. 10.2 Form of Capped Call Confirmation. 99.1 Press Release of Zoetis Inc., dated December 15, 2025 relating to launch of the Offering. 99.2 Press Release of Zoetis Inc., dated December 16, 2025 relating to pricing of the Offering. 104 Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZOETIS INC. Dated: December 18, 2025 By: /s/ Roxanne Lagano Roxanne Lagano Executive Vice President, General Counsel and Corporate Secretary